Company Filing History:
1 out of 16 
1 out of 155 Years Active: 2007
Title: The Innovative Contributions of Wan Hee Yoon in Cancer Research
Introduction: Wan Hee Yoon, an esteemed inventor based in Taejon, South Korea, has made significant strides in the field of cancer research through his innovative work on peptides. With one patent to his name, Yoon's research focuses on peptides that inhibit the activity of vascular endothelial growth factor (VEGF), which plays a critical role in angiogenesis and tumor growth.
Latest Patents: Wan Hee Yoon's patent encompasses the development of arginine-rich anti-VEGF peptides, which are specifically designed to inhibit the growth and metastasis of human tumor cells by blocking angiogenesis. This groundbreaking invention targets the binding of VEGF to its receptors on vascular endothelial cells, effectively impairing the hormonal activity necessary for cancer development. The combinatorial library of peptides synthesized during this research demonstrates their potential to treat a variety of angiogenesis-related diseases, including cancer, diabetic retinopathy, and rheumatoid arthritis.
Career Highlights: Throughout his professional journey, Wan Hee Yoon has contributed to various significant projects while working with reputable organizations such as Korea Greencross Corporation and Postech Foundation. His expertise in peptide synthesis and cancer therapeutics showcases his commitment to advancing medical science and improving patient outcomes.
Collaborations: Yoon has collaborated with notable colleagues in his research endeavors, including Chi Bom Chae and Dong Goo Bae. These partnerships have played a vital role in enhancing the efficacy and applicability of his innovative peptides.
Conclusion: Wan Hee Yoon’s contributions to cancer research through his patent on anti-VEGF peptides highlight the critical role of innovation in combating life-threatening diseases. His work not only advances our understanding of angiogenesis but also offers hope for new treatment options for patients suffering from various angiogenesis-related conditions. As research continues to evolve, the impact of Yoon's inventions may pave the way for significant advancements in medical treatments.